Measurement of matrix metalloproteinases in serum of patients with melanoma: snarled in technical pitfalls.
Zucker
Stanley
S
Veterans Affairs Medical Center, Northport, New York 11768, USA. s.zucker@yohoo.com
Cao
Jian
J
D000970:Antineoplastic Agents / Q000627:therapeutic use; D014408:Biomarkers, Tumor / Q000097:blood*; D006403:Hematologic Tests / Q000379:methods; D006801:Humans; D016898:Interferon-alpha / Q000627:therapeutic use; D020780:Matrix Metalloproteinase 9 / Q000097:blood*; D008545:Melanoma / Q000188:drug therapy / Q000473:pathology*; D011379:Prognosis; D015203:Reproducibility of Results; D012878:Skin Neoplasms / Q000188:drug therapy / Q000473:pathology*
D000970:Antineoplastic Agents; D014408:Biomarkers, Tumor; D016898:Interferon-alpha; D020780:Matrix Metalloproteinase 9